POTELIGEO
NDC 42747-761, mogamulizumab-kpkc, injection, from Kyowa Kirin, Inc..
- Product NDC
- 42747-761
- Status
- Listed
- Labeler
- Kyowa Kirin, Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761051
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42747-761 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MOGAMULIZUMAB4 mg/mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Chemokine Receptor Type 4 Interaction [EPC]; Chemokine Receptor Type 4 Interactions [MoA]; Monoclonal Antibody [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42747-761-01 | 42747076101 | 1 VIAL, GLASS in 1 CARTON (42747-761-01) / 5 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e53960ab-42a1-40d1-9c7d-eb013fe7f18fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=42747-761
Use it
Look up 42747-761 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42747-761 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42747-761. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.